<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03009136</url>
  </required_header>
  <id_info>
    <org_study_id>ISEE_2015_SCRT</org_study_id>
    <nct_id>NCT03009136</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis</brief_title>
  <official_title>Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis: Study Protocol for a Double-blind, Randomized, Parallel-group, Multi-center Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyung Hee University Hospital at Gangdong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kyung Hee University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Semyung University Affiliated Oriental Medical Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>DongGuk University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kyung Hee University Hospital at Gangdong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the short and long term efficacy and the safety of
      SCRT treatment for PAR
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 31, 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Total Nasal Symptom score</measure>
    <time_frame>At baseline, week 2, 4, 8, 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score</measure>
    <time_frame>At baseline, week 2, 4, 8, 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Total serum IgE level</measure>
    <time_frame>At baseline, week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in eosinophil count</measure>
    <time_frame>At baseline, week 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cytokine level</measure>
    <time_frame>At baseline, week 4</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Perennial Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>SCRT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3g, three times a day, each taken before or between meals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>3g, three times a day, each taken before or between meals</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SCRT</intervention_name>
    <description>composed of eight herbs: Glycyrrhiza uralensis Fischer 1g Zingiber officinale Roscoe 0.5g Cinnamomum cassia Blume 0.2g, Ephedra sinica Stapf 0.5g, Pinellia ternata Breitenbach 2.67g, Paeonia lactiflora PALL 1g, Asiasarum sieboldi F. Maekawa 0.5g, Schisandra chinensis 2.67g (per 9g of granules)</description>
    <arm_group_label>SCRT group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>is made of lactose, corn starch and caramel coloring, and has appearance, shape, weight, taste, and color similar to SCRT</description>
    <arm_group_label>placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 18-60 years

          2. presence of two or more nasal symptoms (rhinorrhea, nasal congestion, nasal itching
             and sneezing) with severity score ≥ 2 (0 = no symptom, 1 = mild symptom, 2 = moderate
             symptom, and 3=severe symptom)

          3. presence of nasal symptoms more than 2 consecutive years; and

          4. positive reaction to the one or more perennial allergen in skin prick test.

        Exclusion Criteria:

          1. treatment with nasal/oral corticosteroids within the past month; nasal cromolyn or
             tricyclic antidepressants within the past two weeks; or nasal/oral decongestants,
             nasal/oral antihistamines, or antileukotrienes within the past week

          2. presence of rhinosinusitis (paranasal sinus X-ray demonstrating mucosal thickening, or
             partial or complete opacification of the paranasal sinuses)

          3. presence of hypertension (systolic ≥ 180 mmHg or diastolic ≥ 100 mmHg)

          4. presence of abnormal liver function (aspartate transaminase (AST) or alanine
             transaminase (ALT) ≥ 100 IU/L) or abnormal renal function (blood urea nitrogen (BUN) ≥
             30 mg/dL or creatinine ≥ 1.8 mg/dL (male), 1.5 mg/dL (female))

          5. presence of neoplasm, severe systemic inflammation, other systemic disease that
             affects rhinitis

          6. history of drug allergy

          7. history of anaphylaxis for allergic tests

          8. pregnancy or lactation

          9. participation of other clinical study within the past 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Minhee Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyung Hee University Hospital at Gangdong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Youme Ko</last_name>
    <phone>822-961-9278</phone>
    <email>iseeymk@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kyung Hee University Hospital at Gangdong</name>
      <address>
        <city>Seoul</city>
        <zip>05278</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youme Ko, MD(TCM)</last_name>
      <phone>82-2-961-9278</phone>
      <email>meyougo@khu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Minhee Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2016</study_first_submitted>
  <study_first_submitted_qc>January 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2017</study_first_posted>
  <last_update_submitted>March 12, 2017</last_update_submitted>
  <last_update_submitted_qc>March 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyung Hee University Hospital at Gangdong</investigator_affiliation>
    <investigator_full_name>Minhee Kim</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Perennial Allergic Rhinitis</keyword>
  <keyword>Herbal Medicine</keyword>
  <keyword>Korean Medicine</keyword>
  <keyword>So-Cheong-Ryong-Tang</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

